JBI evidence synthesis最新文献

Objective: The objective of this review is to synthesize the evidence on the effectiveness of various dosage parameters (session duration, frequency, and total intervention period), including their potential dose-response impact (if meta-analysis is feasible), on postural control and balance using Wii Fit Plus balance exergaming in stroke patients.

Introduction: Wii Fit Plus is an innovative exergaming tool that consists of interactive standing balance exercises to improve balance and postural control in stroke patients. However, the optimal treatment effects and dosage response for achieving these outcomes remain unclear.

Eligibility criteria: This review will consider randomized controlled trials, quasi-experimental studies, and other types of experimental studies evaluating preliminary efficacy or effectiveness of Wii Fit Plus balance exergames for adults and older adults post-stroke. The comparators will include standard-care physiotherapy and alternative exergaming interventions. The outcome of interest will be postural control and balance, quality of life, functional independence, gait performance, and functional mobility.

Methods: A systematic search will be conducted across PubMed, Embase, Scopus, PEDro, Web of Science, and CINAHL (EBSCOhost) for studies published from 2010 onwards. The review will follow JBI methodology for systematic reviews of effectiveness. Study selection, data extraction, and critical appraisal will be independently performed by 2 reviewers. Dose-response meta-analysis (DRMA) using a random-effects model will be used to estimate pooled effect size, with subgroup analyses exploring dosing variations. If meta-analysis is not feasible, a narrative synthesis will be conducted. The overall strength of the evidence will be determined using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.

Review registration: PROSPERO CRD42025641558.

Objective: The objective of this scoping review will be to systematically organize and analyze the existing rehabilitation programs and exercises for inpatients, particularly older adults, with proximal hip fragility fractures, focusing on the characteristics and methods of exercise programs. This knowledge will provide a better understanding of the existing evidence base and inform about future research.

Introduction: Hip fractures are a leading cause of disability and long-term care needs among older adults, with rising incidence due to aging. Early and effective rehabilitation is essential, yet existing research often focuses on single interventions or specific aspects of rehabilitation. For inpatients who are 65 years or older, a comprehensive analysis of rehabilitation programs and exercise interventions is needed, in line with the FITT-VP framework and incorporating multidisciplinary involvement.

Eligibility criteria: This scoping will include studies involving inpatients aged 65 years or older who have undergone surgical treatment for a single proximal hip fragility fracture and received inpatient rehabilitation in the same hospital. Studies must describe rehabilitation programs or exercise interventions.

Methods: This review will follow the JBI methodology for scoping reviews. The databases to be searched will include PubMed, CINAHL Ultimate (EBSCOhost), Embase, Web of Science Core Collection, Cochrane Library, Scopus, JBI EBP Database (Ovid), PEDro, and Epistemonikos, and fragility fracture-related websites. The search will be conducted from January 2015 to February 2025, with no language or country restrictions. Two independent reviewers will screen and extract data, with disagreements resolved by a third reviewer. Data will be charted and presented using the FITT-VP framework, with results in tabular and narrative format to highlight characteristics and trends.

Review registration: OSF https://doi.org/10.17605/OSF.IO/CYSNG.

Objective: This scoping review will identify and map the available literature on virtual care for chronic wound management in residential aged care settings.

Introduction: Chronic wounds are an underacknowledged public health issue with substantial health and economic costs. These wounds, which do not heal in a timely manner, are common in residential aged care settings. While evidence-based wound care is essential for better outcomes, access is challenging in residential aged care settings. Emerging virtual care interventions have improved access to evidence-based wound care; however, little is known about the current use of such interventions in residential aged care settings.

Eligibility criteria: This review will include adults with chronic wounds living in residential aged care across diverse geographic locations. The review will consider virtual care for chronic wounds, with a particular focus on intervention type and frequency, as well as barriers and enablers of use.

Methods: The proposed review will be conducted in accordance with the JBI methodology for scoping reviews and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). MEDLINE (Ovid), CINAHL (EBSCOhost), Embase (Ovid), AgeLine, IEEE Xplore, and ACM digital library will be searched for relevant literature, with no limitations on language or date of publication. The World Health Organization's International Clinical Trials Registry Platform (WHO ICTRP) and the US National Institutes of Health Ongoing Trials Register will be searched for gray literature. Title, abstract, and full-text screening will be conducted by 2 reviewers independently. Data will be extracted using a reviewer-developed tool, and a narrative summary will accompany the tabulated results.

Review registration: OSF https://osf.io/j97bt.

Objective: The objective of this systematic review is to evaluate the effectiveness of artificial intelligence-enhanced cognitive behavioral therapy (AI-enhanced CBT) compared to traditional CBT or alternative non-pharmacological therapies in treating depression and anxiety among adults.

Introduction: Mental health disorders, particularly anxiety and depression, affect millions of individuals worldwide. The World Health Organization estimated that in 2021, approximately 359 million people experienced anxiety and 332 million experienced depression, with global prevalence rates of 4.4% and 4.0%, respectively. CBT has long been an effective treatment for these conditions, with structured interventions for symptom reduction. However, AI-enhanced CBT introduces a new dimension by personalizing treatment through adaptive algorithms and automated feedback. While traditional therapies such as psychotherapy, medication, or mindfulness have shown varying degrees of success, the integration of AI with CBT holds potential for scalable, accessible, and individualized care.

Eligibility criteria: This review will include studies that evaluate AI-enhanced CBT for treating adults with depression and/or anxiety. Comparators may include traditional CBT or alternative non-pharmacological interventions. Eligible studies must report clinical outcomes such as symptom reduction, patient engagement, or treatment feasibility.

Methods: The review will follow the JBI methodology for systematic reviews of effectiveness. Comprehensive searches will be conducted in MEDLINE (Ovid), Scopus, Cochrane CENTRAL, CINAHL (Ovid), Embase (Ovid), and Epistemonikos. We will also search relevant gray literature sources, including ProQuest Dissertations and Theses Global (EBSCOhost), OAIster, and Google Scholar. Two reviewers will independently screen studies, appraise quality using the JBI checklist for randomized controlled trials, and extract data using a standardized form. The review will follow PRISMA reporting guidelines, and, if data permit, meta-analysis will be undertaken.

Review registration: PROSPERO CRD42024580549.

Objective: The aim of the scoping review is to elucidate challenges in mass drug administration programs with ivermectin to control or eliminate onchocerciasis in endemic countries.

Introduction: The filarial nematode Onchocerca volvulus causes onchocerciasis, a neglected tropical disease that can lead to blindness. Although ivermectin, a potent antifilarial drug, was introduced in 1991 and has been used successfully in mass drug administration programs, complex challenges have prevented the elimination of onchocerciasis, a goal set by the World Health Organization in 2009. A comprehensive understanding of these challenges could help program managers and policymakers better target their efforts to control and eliminate onchocerciasis.

Eligibility criteria: This review will consider literature that includes individuals affected by onchocerciasis who are living in endemic countries. Literature describing the challenges of implementing mass drug administration programs with ivermectin to control or eliminate onchocerciasis will be considered.

Methods: The review will be conducted according to the JBI methodology for scoping reviews and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). MEDLINE (Ovid), Web of Science Core Collection, CINAHL (EBSCOhost), Cochrane Central Register of Controlled Trials (CENTRAL), Emcare (Ovid), Embase (Ovid), Scopus, and SciELO will be searched. Primary and gray literature in any language from January 1991 onward will be included. Additional studies will be identified by screening the reference lists of included articles. Study selection and data extraction will be done independently by 2 reviewers. Data will be analyzed descriptively and presented in tables, graphs, and narrative format.

Review registration: OSF https://osf.io/e2q49.

Objective: The proposed scoping review will identify and map the literature on allied health interventions for preterm infants with feeding aversion.

Introduction: Infants born preterm can have aversive responses to food in the mouth (eg, avoidance, gagging), which can lead to refusal to eat, poor diet, poor weight gain, long-term tube feeding, and stress and anxiety during mealtimes. There is currently limited evidence on allied health professional interventions for infants with feeding aversion and their families. A comprehensive scoping review will identify allied health interventions to address this issue, as well as potential evidence gaps.

Eligibility criteria: Eligible studies will include infants born preterm (≤37 weeks' gestational age), aged ≤12 months (corrected age), with feeding aversion, and their parents/families. Studies will also be eligible if they report on allied health (speech and language therapy, occupational therapy, dietetic, psychology) interventions to improve infants' oral feeding.

Methods: The review will follow the JBI methodology for scoping reviews. MEDLINE (Ovid), AMED (Ovid), Embase (Ovid), Emcare (Ovid), PsycINFO (ProQuest), and CINAHL (EBSCOhost) databases will be searched from January 2014 onward. PubMed will be searched in its entirety for cited and similar articles. Hand-searches of gray literature, reference lists, and specific professional publications will also be conducted. No language restrictions will be applied. Data published in languages other than English will be translated using free online translation tools. Two reviewers will independently screen studies and extract data using a piloted data extraction form. Descriptive analysis will include narrative summaries, frequency counts, descriptive statistics, and/or basic descriptive qualitative coding and categorizing.

Review registration: Figshare https://figshare.com/articles/preprint/Allied_health_interventions_for_preterm_infants_with_feeding_aversion_Protocol_abstract/26954929.

Objective: This systematic review will aim to evaluate the effectiveness of telemedicine interventions compared with traditional or in-person care in improving medication adherence and clinical outcomes among adult patients with tuberculosis in low- and middle-income countries.

Introduction: Tuberculosis remains a major public health challenge, particularly in low- and middle-income countries, where health care access is limited and treatment adherence is suboptimal. Telemedicine interventions, including video-observed therapy, text message reminders, and mobile health applications, offer innovative solutions to enhance tuberculosis management. However, evidence on their effectiveness remains fragmented, especially in low-resource settings, necessitating a comprehensive review to inform policy and practice.

Eligibility criteria: This review will include randomized controlled trials and quasi-experimental studies conducted in low- and middle-income countries involving adult patients with tuberculosis. Eligible studies will evaluate telemedicine interventions with a minimum duration of 30 days and report on at least 1 primary outcome (medication adherence or tuberculosis clinical outcomes) or secondary outcome (acceptability or patient satisfaction).

Methods: The review will adhere to the JBI methodology for systematic reviews of effectiveness. A 3-step search strategy will be followed to identify published and unpublished studies and gray literature. Databases to be searched will include PubMed, CINAHL (EBSCOhost), Embase (Ovid), Global Health (Ovid), and ScienceDirect. There will be no date or language restrictions. Two reviewers will independently screen and select studies, critically appraise studies, and extract data. If feasible, a meta-analysis will be conducted; otherwise, the synthesis without meta-analysis (SWiM) approach to data synthesis will be used. The GRADE approach will assess evidence certainty, and the findings will be summarized accordingly.

Review registration: PROSPERO CRD42025644658.